# Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML

> **NCT04973618** · PHASE1 · WITHDRAWN · sponsor: **Aptevo Therapeutics**

## Conditions studied

- AML

## Interventions

- **BIOLOGICAL:** APVO436

## Key facts

- **NCT ID:** NCT04973618
- **Lead sponsor:** Aptevo Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-01
- **Primary completion:** 2026-01
- **Final completion:** 2027-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change of strategy
- **Last updated:** 2021-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04973618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04973618, "Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04973618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*